Protara Therapeutics (TARA) Total Non-Current Liabilities (2013 - 2016)

Protara Therapeutics (TARA) has reported Total Non-Current Liabilities for 4 consecutive years, with $4.8 million the latest figure, recorded in Q3 2016.

• In Q3 2016, Total Non-Current Liabilities rose 52.9% year-over-year to $4.8 million; the TTM figure through Sep 2016 stood at $4.8 million (up 52.9% YoY), while the FY2015 annual figure was $3.6 million, changed N/A from the prior year.
• Total Non-Current Liabilities climbed to $4.8 million in Q3 2016 per TARA's latest filing, from $4.5 million in the prior quarter.
• Across five years, Total Non-Current Liabilities topped out at $8.3 million in Q4 2013 and bottomed at $2.7 million in Q3 2014.
• Historically, Total Non-Current Liabilities has averaged $4.1 million across 4 years, with a median of $3.4 million in 2015.
• Annual changes were most pronounced in 2015 — Total Non-Current Liabilities rose 19.19% — and 2016, when it surged 62.64%.
• Protara Therapeutics' Total Non-Current Liabilities stood at $8.3 million in 2013, then sank by 68.07% to $2.7 million in 2014, then soared by 35.29% to $3.6 million in 2015, then jumped by 34.71% to $4.8 million in 2016.
• Business Quant data shows TARA's Total Non-Current Liabilities at $4.8 million in Q3 2016, $4.5 million in Q2 2016, and $3.3 million in Q1 2016.